BioLineRx Ltd (BLRX) — Capital Reinvestment Ratio
Latest as of December 2023:
0.00x
BioLineRx Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($4.99 Million) in capital expenditures ($18.00K). See BioLineRx Ltd (BLRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$4.99 Million
USD
Capital Expenditures
$18.00K
USD
Data as of
Dec 2023
Most recent filing
BioLineRx Ltd Capital Reinvestment Ratio (2010–2010)
This chart tracks BioLineRx Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for BioLineRx Ltd (2010–2010)
Year-by-year Capital Reinvestment Ratio for BioLineRx Ltd from 2010 to 2010. For live market cap and broader valuation context, see BioLineRx Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.06x | $11.46 Million | $660.94K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow